AI Bias Analysis
4 models · Takes ~15 seconds
(MedPage Today) -- The FDA on Friday approved belzutifan (Welireg) plus pembrolizumab (Keytruda, Keytruda Qlex) as adjuvant therapy for renal cell carcinoma (RCC) with a clear cell component. Based on results from LITESPARK-022, the combination...
Source
MedPage Today
Opens original article in a new tab
Trump administration revisits policy to plug Medicare drug price negotiation loophole.
(MedPage Today) -- A 2010 paper that linked hepatitis B vaccines in infant boys to an increased risk of autism diagnosis was retracted and another study by the same authors is under investigation. The study, published in the Journal of Toxicology...
(MedPage Today) -- Alcohol consumption during pregnancy has been on the rise in recent years, with some groups, like unmarried women and women in frequent distress, more likely to partake, CDC data showed. Responding to a survey, 15.2% of pregnant...
(MedPage Today) -- The FDA approved capivasertib (Truqap) in combination with abiraterone (Zytiga) and prednisone for PTEN-deficient prostate cancer, the agency announced on Friday. Approval stipulates use in metastatic hormone-sensitive prostate...
